User login
Article Type
Changed
Thu, 12/15/2022 - 15:10
Display Headline
Interaction Between Adalimumab With Concurrent Pregabalin and Duloxetine Administration in a Psoriasis Patient With Diabetic Peripheral Neuropathy [letter]
Article PDF
Issue
Cutis - 87(5)
Topics
Page Number
249,250
Sections
Article PDF
Article PDF
Issue
Cutis - 87(5)
Issue
Cutis - 87(5)
Page Number
249,250
Page Number
249,250
Topics
Article Type
Display Headline
Interaction Between Adalimumab With Concurrent Pregabalin and Duloxetine Administration in a Psoriasis Patient With Diabetic Peripheral Neuropathy [letter]
Display Headline
Interaction Between Adalimumab With Concurrent Pregabalin and Duloxetine Administration in a Psoriasis Patient With Diabetic Peripheral Neuropathy [letter]
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document